WELCOME TO THE PORTAL

A spotlight for innovative companies. A resource for institutional investors.

DISCOVER MORE

Our Corporate Access Portal serves as a tool to inform and engage investors by providing in-depth investor profiles for selected public companies and aims to facilitate meaningful one-on-one meetings between investors and company executives.

Investors can unlock captivating fireside chats and company webcasts; discover insightful KOL panels with public company executives and industry experts; and stay informed with real-time stock data, SEC filings, press releases and more.

Explore our Featured Companies and schedule your one-on-one meetings today!

View Featured Companies

GET TO KNOW OUR COMPANIES

Spotlight on Cadrenal Therapeutics

Cadrenal (Nasdaq: CVKD) is a late-stage biopharmaceutical company developing tecarfarin, a new vitamin K antagonist (VKA) designed to offer safer, more effective chronic anticoagulation for patients with implanted cardiac devices or rare cardiovascular conditions. 

View Investor Profile

FALL 2024 INVESTOR CONFERENCE

October 1, 2024  |  Virtual Investor Conference

Did you miss our Fall 2024 Investor Conference? No worries! You can catch everything you missed here.

View panels and webcasts

BECOME A FEATURED COMPANY

Unlock opportunities to showcase your company to a vast audience of investors.

Become a Featured Company today!

REQUEST INFORMATION

GET TO KNOW OUR COMPANIES

Interested in learning more about our Featured Companies?

Request a 1×1 meeting with management.

REQUEST 1X1 MEETINGS

RECENT NEWS

View All News

RECENT EVENTS

View All Events
Skip to content